Renalytix repays $1.06M of convertible bonds with ADSs; outstanding principal now $12.72M

Renalytix plc

Issued 1,818,081 ADSs (3,636,162 ordinary shares) on April 11, 2024 to settle $1.06M of principal and interest due April 7, 2024.
Principal remaining on 5.5% convertible bonds due April 2027 reduced by $1.06M to $12.72M.
New ordinary shares admitted to AIM on April 12, 2024; total voting rights rise to 123,552,349.
Shares issued without SEC registration under Section 3(a)(9) exemption.
Repayment covers quarterly installment for period from January 8, 2024 to April 7, 2024.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.